Biolidics shares sink 22% after calling off US sales of Covid-19 test kits, Companies & Markets

Biolidics shares sink 22% after calling off US sales of Covid-19 test kits, Companies & Markets

Singapore BIOLIDICS shares sank 22 per cent on Monday after the Catalist-listed firm announced on Sunday that it had mutually agreed with Aytu BioScience to terminate a distribution agreement for its Covid-19 antibody test kits in the US, amid increased competition for such kits. … Click here for the full story.

Biolidics’ Covid-19 rapid test kit allowed to be sold in EU, Companies & Markets
Biolidics’ 10-minute virus test kit gets official greenlight in the Philippines, Companies & Markets
Biolidics to distribute Covid-19 rapid test kits in US, Companies & Markets


Singapore

BIOLIDICS shares sank 22 per cent on Monday after the Catalist-listed firm announced on Sunday that it had mutually agreed with Aytu BioScience to terminate a distribution agreement for its Covid-19 antibody test kits in the US, amid increased competition for such kits.





Click here for the full story.

COMMENTS

WORDPRESS: 0
DISQUS: